Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.89
Delayed Data
As of 3:59pm ET
 +0.12 / +2.52%
Today’s Change
3.61
Today|||52-Week Range
11.15
-20.23%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close4.77
Today’s open4.80
Day’s range4.70 - 4.97
Volume331,063
Average volume (3 months)905,378
Market cap$333.6M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-1,033.33%
Earnings growth (this year)+117.41%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-80.45%
P/E ratioNM
Price/Sales49.26
Price/Book3.69

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...-0.03-0.34%
NERVMinerva Neuroscience...-0.48-4.07%
NHTCNatural Health Trend...+0.49+1.73%
KPTIKaryopharm Therapeut...+0.09+0.94%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$0.05
Annual revenue (last year)$8.7M
Annual profit (last year)-$39.1M
Net profit margin-450.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Head-
Operations
Meryl J. Longval
Corporate headquarters
Tarrytown, New York

Forecasts

Partner Offers

Search for Jobs